Target intelligence / Profile preview

Host epithelial cell (and associated immune pathways)

Molecular classification
Other
01

Overview

Host epithelial cells are specialized cells lining the surfaces of organs and tissues (such as the respiratory and gastrointestinal tracts) that form a physical and functional barrier between the external environment and internal tissues. They possess intrinsic immune capabilities, including pathogen sensing via pattern recognition receptors, secretion of antimicrobial peptides, cytokines, chemokines, and antigen presentation machinery such as major histocompatibility complex II (MHCII). Epithelial cells coordinate immune responses by interacting with and recruiting immune cells, contribute to tissue repair, regulate tolerance to commensals and dietary antigens, and can undergo regulated cell death (apoptosis) to limit pathogen spread. Their interactions with immune pathways are complex, highly context-dependent, and central to host defense, tissue homeostasis, and disease states such as infection, chronic inflammation, and cancer[1][2][3][4][5][7]. Notes on Target Validity - "Host epithelial cells and associated immune pathways" refers to a broad, complex set of cell types and signaling relationships, not a single molecular entity, protein, receptor, or well-defined therapeutic target. - Therapeutic targeting is better defined for specific molecular targets expressed by epithelial cells (such as cytokine receptors, pattern recognition receptors, or MHC class II molecules). - The entry as provided is overly broad and non-specific; more precise naming would be necessary for structured drug discovery or molecular target mapping tasks[1][2][3][5][7].

Other names
Epithelial cell (host)Mucosal epithelial cellAirway epithelial cellIntestinal epithelial cellIECAirway epitheliumEpithelial barrier
02

Biological functions

Immune responseBarrier functionSignal transductionAntigen presentationCell proliferationApoptosisWound healingMucus productionAntimicrobial peptide secretionCytokine/chemokine signaling
03

Disease associations

InfectionInflammationCancerAutoimmune diseaseAllergic diseaseOther
04

Safety considerations

Broad targeting of epithelial cells may disrupt normal barrier integrity and immune homeostasisModulating epithelial-immune interactions carries a risk of exacerbating infection, inflammation, or autoimmunity

Beyond the preview

Go deeper on Host epithelial cell (and associated immune pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host epithelial cell (and associated immune pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call